Moreover, the S-enantiomer of mepazine, s-mepazine, in combination with the BTK inhibitor ibrutinib, also induced a reduction in MALT1 activity in ABC-DLBCL cell lines [189]. The gene discussed is BTK; the disease is diffuse large B-cell lymphoma.